Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)

Zbigniew Kalarus; Jesper Hastrup Svendsen; Davide Capodanno; Gheorghe-Andrei Dan; Elia De Maria; Bulent Gorenek; Ewa Jędrzejczyk-Patej; Michał Mazurek; Tomasz Podolecki; Christian Sticherling; Jacob Tfelt-Hansen; Vassil Traykov; Gregory Y H Lip; Laurent Fauchier; Giuseppe Boriani; Jacques Mansourati; Carina Blomström-Lundqvist; Georges H Mairesse; Andrea Rubboli; Thomas Deneke; Nikolaos Dagres; Torkel Steen; Ingo Ahrens; Vijay Kunadian; Sergio Berti

doi:10.1093/europace/euz163

Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)

Zbigniew Kalarus, Jesper Hastrup Svendsen, Davide Capodanno, Gheorghe-Andrei Dan, Elia De Maria, Bulent Gorenek, Ewa Jędrzejczyk-Patej, Michał Mazurek, Tomasz Podolecki, Christian Sticherling, Jacob Tfelt-Hansen, Vassil Traykov, Gregory Y H Lip, Laurent Fauchier, Giuseppe Boriani, Jacques Mansourati, Carina Blomström-Lundqvist, Georges H Mairesse, Andrea Rubboli, Thomas DenekeNikolaos Dagres, Torkel Steen, Ingo Ahrens, Vijay Kunadian, Sergio Berti

18 Citationer (Scopus)

Abstract

Despite major therapeutic advances over the last decades, complex supraventricular and ventricular arrhythmias (VAs), particularly in the emergency setting or during revascularization for acute myocardial infarction (AMI), remain an important clinical problem. Although the incidence of VAs has declined in the hospital phase of acute coronary syndromes (ACS), mainly due to prompt revascularization and optimal medical therapy, still up to 6% patients with ACS develop ventricular tachycardia and/or ventricular fibrillation within the first hours of ACS symptoms. Despite sustained VAs being perceived predictors of worse in-hospital outcomes, specific associations between the type of VAs, arrhythmia timing, applied treatment strategies and long-term prognosis in AMI are vague. Atrial fibrillation (AF) is the most common supraventricular tachyarrhythmia that may be asymptomatic and/or may be associated with rapid haemodynamic deterioration requiring immediate treatment. It is estimated that over 20% AMI patients may have a history of AF, whereas the new-onset arrhythmia may occur in 5% patients with ST elevation myocardial infarction. Importantly, patients who were treated with primary percutaneous coronary intervention for AMI and developed AF have higher rates of adverse events and mortality compared with subjects free of arrhythmia. The scope of this position document is to cover the clinical implications and pharmacological/non-pharmacological management of arrhythmias in emergency presentations and during revascularization. Current evidence for clinical relevance of specific types of VAs complicating AMI in relation to arrhythmia timing has been discussed.

Originalsprog	Engelsk
Tidsskrift	Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Vol/bind	21
Udgave nummer	10
Sider (fra-til)	1603–1604p
Antal sider	18
ISSN	1099-5129
DOI	https://doi.org/10.1093/europace/euz163
Status	Udgivet - 1 okt. 2019

Adgang til dokumentet

10.1093/europace/euz163

euz163.pdfForlagets udgivne version, 1,19 MB

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Kalarus, Z., Svendsen, J. H., Capodanno, D., Dan, G-A., De Maria, E., Gorenek, B., Jędrzejczyk-Patej, E., Mazurek, M., Podolecki, T., Sticherling, C., Tfelt-Hansen, J., Traykov, V., Lip, G. Y. H., Fauchier, L., Boriani, G., Mansourati, J., Blomström-Lundqvist, C., Mairesse, G. H., Rubboli, A., ... Berti, S. (2019). Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 21(10), 1603–1604p. https://doi.org/10.1093/europace/euz163

Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization : an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). / Kalarus, Zbigniew; Svendsen, Jesper Hastrup; Capodanno, Davide et al.

I: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Bind 21, Nr. 10, 01.10.2019, s. 1603–1604p.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Kalarus, Z, Svendsen, JH, Capodanno, D, Dan, G-A, De Maria, E, Gorenek, B, Jędrzejczyk-Patej, E, Mazurek, M, Podolecki, T, Sticherling, C, Tfelt-Hansen, J, Traykov, V, Lip, GYH, Fauchier, L, Boriani, G, Mansourati, J, Blomström-Lundqvist, C, Mairesse, GH, Rubboli, A, Deneke, T, Dagres, N, Steen, T, Ahrens, I, Kunadian, V & Berti, S 2019, 'Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)', Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, bind 21, nr. 10, s. 1603–1604p. https://doi.org/10.1093/europace/euz163

Kalarus Z, Svendsen JH, Capodanno D, Dan G-A, De Maria E, Gorenek B et al. Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2019 okt. 1;21(10):1603–1604p. doi: 10.1093/europace/euz163

Kalarus, Zbigniew ; Svendsen, Jesper Hastrup ; Capodanno, Davide et al. / Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization : an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). I: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2019 ; Bind 21, Nr. 10. s. 1603–1604p.

@article{86cd84e6e7864dc88982521936fefb1a,

title = "Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)",

abstract = "Despite major therapeutic advances over the last decades, complex supraventricular and ventricular arrhythmias (VAs), particularly in the emergency setting or during revascularization for acute myocardial infarction (AMI), remain an important clinical problem. Although the incidence of VAs has declined in the hospital phase of acute coronary syndromes (ACS), mainly due to prompt revascularization and optimal medical therapy, still up to 6% patients with ACS develop ventricular tachycardia and/or ventricular fibrillation within the first hours of ACS symptoms. Despite sustained VAs being perceived predictors of worse in-hospital outcomes, specific associations between the type of VAs, arrhythmia timing, applied treatment strategies and long-term prognosis in AMI are vague. Atrial fibrillation (AF) is the most common supraventricular tachyarrhythmia that may be asymptomatic and/or may be associated with rapid haemodynamic deterioration requiring immediate treatment. It is estimated that over 20% AMI patients may have a history of AF, whereas the new-onset arrhythmia may occur in 5% patients with ST elevation myocardial infarction. Importantly, patients who were treated with primary percutaneous coronary intervention for AMI and developed AF have higher rates of adverse events and mortality compared with subjects free of arrhythmia. The scope of this position document is to cover the clinical implications and pharmacological/non-pharmacological management of arrhythmias in emergency presentations and during revascularization. Current evidence for clinical relevance of specific types of VAs complicating AMI in relation to arrhythmia timing has been discussed.",

author = "Zbigniew Kalarus and Svendsen, {Jesper Hastrup} and Davide Capodanno and Gheorghe-Andrei Dan and {De Maria}, Elia and Bulent Gorenek and Ewa J{\c e}drzejczyk-Patej and Micha{\l} Mazurek and Tomasz Podolecki and Christian Sticherling and Jacob Tfelt-Hansen and Vassil Traykov and Lip, {Gregory Y H} and Laurent Fauchier and Giuseppe Boriani and Jacques Mansourati and Carina Blomstr{\"o}m-Lundqvist and Mairesse, {Georges H} and Andrea Rubboli and Thomas Deneke and Nikolaos Dagres and Torkel Steen and Ingo Ahrens and Vijay Kunadian and Sergio Berti",

year = "2019",

month = oct,

day = "1",

doi = "10.1093/europace/euz163",

language = "English",

volume = "21",

pages = "1603–1604p",

journal = "Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization

T2 - an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)

AU - Kalarus, Zbigniew

AU - Svendsen, Jesper Hastrup

AU - Capodanno, Davide

AU - Dan, Gheorghe-Andrei

AU - De Maria, Elia

AU - Gorenek, Bulent

AU - Jędrzejczyk-Patej, Ewa

AU - Mazurek, Michał

AU - Podolecki, Tomasz

AU - Sticherling, Christian

AU - Tfelt-Hansen, Jacob

AU - Traykov, Vassil

AU - Lip, Gregory Y H

AU - Fauchier, Laurent

AU - Boriani, Giuseppe

AU - Mansourati, Jacques

AU - Blomström-Lundqvist, Carina

AU - Mairesse, Georges H

AU - Rubboli, Andrea

AU - Deneke, Thomas

AU - Dagres, Nikolaos

AU - Steen, Torkel

AU - Ahrens, Ingo

AU - Kunadian, Vijay

AU - Berti, Sergio

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Despite major therapeutic advances over the last decades, complex supraventricular and ventricular arrhythmias (VAs), particularly in the emergency setting or during revascularization for acute myocardial infarction (AMI), remain an important clinical problem. Although the incidence of VAs has declined in the hospital phase of acute coronary syndromes (ACS), mainly due to prompt revascularization and optimal medical therapy, still up to 6% patients with ACS develop ventricular tachycardia and/or ventricular fibrillation within the first hours of ACS symptoms. Despite sustained VAs being perceived predictors of worse in-hospital outcomes, specific associations between the type of VAs, arrhythmia timing, applied treatment strategies and long-term prognosis in AMI are vague. Atrial fibrillation (AF) is the most common supraventricular tachyarrhythmia that may be asymptomatic and/or may be associated with rapid haemodynamic deterioration requiring immediate treatment. It is estimated that over 20% AMI patients may have a history of AF, whereas the new-onset arrhythmia may occur in 5% patients with ST elevation myocardial infarction. Importantly, patients who were treated with primary percutaneous coronary intervention for AMI and developed AF have higher rates of adverse events and mortality compared with subjects free of arrhythmia. The scope of this position document is to cover the clinical implications and pharmacological/non-pharmacological management of arrhythmias in emergency presentations and during revascularization. Current evidence for clinical relevance of specific types of VAs complicating AMI in relation to arrhythmia timing has been discussed.

AB - Despite major therapeutic advances over the last decades, complex supraventricular and ventricular arrhythmias (VAs), particularly in the emergency setting or during revascularization for acute myocardial infarction (AMI), remain an important clinical problem. Although the incidence of VAs has declined in the hospital phase of acute coronary syndromes (ACS), mainly due to prompt revascularization and optimal medical therapy, still up to 6% patients with ACS develop ventricular tachycardia and/or ventricular fibrillation within the first hours of ACS symptoms. Despite sustained VAs being perceived predictors of worse in-hospital outcomes, specific associations between the type of VAs, arrhythmia timing, applied treatment strategies and long-term prognosis in AMI are vague. Atrial fibrillation (AF) is the most common supraventricular tachyarrhythmia that may be asymptomatic and/or may be associated with rapid haemodynamic deterioration requiring immediate treatment. It is estimated that over 20% AMI patients may have a history of AF, whereas the new-onset arrhythmia may occur in 5% patients with ST elevation myocardial infarction. Importantly, patients who were treated with primary percutaneous coronary intervention for AMI and developed AF have higher rates of adverse events and mortality compared with subjects free of arrhythmia. The scope of this position document is to cover the clinical implications and pharmacological/non-pharmacological management of arrhythmias in emergency presentations and during revascularization. Current evidence for clinical relevance of specific types of VAs complicating AMI in relation to arrhythmia timing has been discussed.

U2 - 10.1093/europace/euz163

DO - 10.1093/europace/euz163

M3 - Journal article

C2 - 31353412

SN - 1099-5129

VL - 21

SP - 1603–1604p

JO - Europace

JF - Europace

IS - 10

ER -